Rayence Co. Ltd
Rayence Co., Ltd., together with its subsidiaries, engages in the development, manufacture, and sale of digital X-ray detector products for dental, medical, veterinary, and industrial sectors in South Korea, the United States, Mexico, China, and internationally. The company offers TFT/CMOS X-ray detectors for general radiography, C-arm/RF, mammography, and radiotherapy; and CMOS/Super IGZO TFT/a-… Read more
Rayence Co. Ltd (228850) - Total Liabilities
Latest total liabilities as of September 2025: ₩26.02 Billion KRW
Based on the latest financial reports, Rayence Co. Ltd (228850) has total liabilities worth ₩26.02 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Rayence Co. Ltd - Total Liabilities Trend (2015–2024)
This chart illustrates how Rayence Co. Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Rayence Co. Ltd Competitors by Total Liabilities
The table below lists competitors of Rayence Co. Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aspire Mining Ltd
AU:AKM
|
Australia | AU$955.33K |
|
Manolete Partners Plc
PINK:MANOF
|
USA | $30.89 Million |
|
TAO Synergies Inc.
NASDAQ:TAOX
|
USA | $1.69 Million |
|
Bizim Toptan Satis Magazalari AS
IS:BIZIM
|
Turkey | TL12.41 Billion |
|
Shagrir Group Vehicle Services Ltd
PINK:SRRPF
|
USA | $337.02 Million |
|
Reyon Pharmaceutical Co Ltd
KO:102460
|
Korea | ₩239.99 Billion |
|
N. B. I. Industrial Finance Company Limited
NSE:NBIFIN
|
India | ₹1.89 Billion |
|
Hyungkuk F&B Co Ltd
KQ:189980
|
Korea | ₩134.09 Billion |
Liability Composition Analysis (2015–2024)
This chart breaks down Rayence Co. Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 14.05 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.11 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.10 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Rayence Co. Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Rayence Co. Ltd (2015–2024)
The table below shows the annual total liabilities of Rayence Co. Ltd from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩24.55 Billion | -33.09% |
| 2023-12-31 | ₩36.69 Billion | -1.51% |
| 2022-12-31 | ₩37.25 Billion | -9.63% |
| 2021-12-31 | ₩41.22 Billion | +12.78% |
| 2020-12-31 | ₩36.55 Billion | -3.24% |
| 2019-12-31 | ₩37.78 Billion | +96.06% |
| 2018-12-31 | ₩19.27 Billion | -2.74% |
| 2017-12-31 | ₩19.81 Billion | -20.56% |
| 2016-12-31 | ₩24.94 Billion | -26.79% |
| 2015-12-31 | ₩34.06 Billion | -- |